- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Alkem's subsidiary Enzene Biosciences received 6 procedural observations from a US regulatory inspection at its Pune plant. Notably, zero data integrity issues were cited. Enzene is implementing corrective actions.